Related Experiment Video

Updated: Jul 4, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Type 2 diabetes-related health measures during the initial COVID-19 surge at an academic internal medicine practice

Lawrence Ma1, Joseph Diaz1, Jennifer Deconde1

  • 1University of California, San Diego, School of Medicine, Department of Medicine.

Primary Care Diabetes
|January 26, 2024
PubMed

Insights

The initial COVID-19 surge had minimal impact on key health markers for patients with Type 2 diabetes. This study found little change in body mass index, blood pressure, cholesterol, or blood glucose control.

Area of Science:

  • Internal Medicine
  • Endocrinology
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted healthcare systems globally.
  • Chronic disease management faced unprecedented challenges during the pandemic.

Purpose of the Study:

  • To assess the impact of the initial COVID-19 surge on key health indicators in Type 2 diabetes patients.
  • To evaluate changes in body mass index, blood pressure, cholesterol, and blood glucose control.

Main Methods:

  • Retrospective analysis of ambulatory general internal medicine patients.
  • Focus on patients with Type 2 diabetes at a single academic center.
  • Comparison of health metrics before and during the initial COVID-19 surge.

Main Results:

  • Minimal changes observed in body mass index.
  • Blood pressure control remained largely unaffected.
  • Cholesterol levels showed no significant disruption.
  • Blood glucose control (HbA1c) demonstrated minimal impact.

Conclusions:

  • The initial phase of the COVID-19 pandemic had a limited effect on the studied health parameters in Type 2 diabetes patients.
  • Ambulatory care at this academic center effectively maintained chronic disease management during the early pandemic.
  • Further research is needed to understand long-term effects and impacts on other patient populations.

Keywords:
COVID-19Chronic disease managementPrimary careType 2 diabetes

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

229

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174